The hydrogel was designed and employed for the targeted delivery of the anti-cancer TRAIL (TNF-related apoptosis-inducing ligand) proteins by Kim et al. The HSA-SH/PEG-MAL hydrogel formed in situ within 60 s in optimal conditions and exhibited an outstanding anti-tumor efficiency [72]. The gene discussed is TNFSF10; the disease is neoplasm.